These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3072284)

  • 1. [Monoclonal antibodies against erythrocytic stages of Plasmodium vivax inhibitory effect on gametocyte infectivity and development within mosquitoes].
    Wang XZ; Hu AQ; Zhu SH; Zan ZX; Bai HA; Yang YH; Dai YR; Cao ZH; Kang WM; Chen HL
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Dec; 19(4):350-3. PubMed ID: 3072284
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.
    Peiris JS; Premawansa S; Ranawaka MB; Udagama PV; Munasinghe YD; Nanayakkara MV; Gamage CP; Carter R; David PH; Mendis KN
    Am J Trop Med Hyg; 1988 Jul; 39(1):26-32. PubMed ID: 3041855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies.
    Udagama PV; David PH; Peiris JS; Ariyaratne YG; Perera KL; Mendis KN
    Infect Immun; 1987 Nov; 55(11):2604-11. PubMed ID: 3312003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
    Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies against erythrocytic stages of Plasmodium vivax: Ig isotype determination and analysis of species and stage-specific immunofluorescein reactions].
    Hu AQ; Zhu SH; Wang XZ; Zan ZX
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Sep; 18(3):195-8. PubMed ID: 3315952
    [No Abstract]   [Full Text] [Related]  

  • 6. Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates.
    Premawansa S; Peiris JS; Perera KL; Ariyaratne G; Carter R; Mendis KN
    J Immunol; 1990 Jun; 144(11):4376-83. PubMed ID: 1692862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The preparation and identification of anti-idiotypic antibody against Plasmodium vivax at erythrocytic stages].
    Bai H; Hu A; Zhu S; Wang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):28-32. PubMed ID: 1383120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax: in vitro development of exoerythrocytic stages in squirrel monkey hepatocytes and inhibition by an anti-P. cynomolgi monoclonal antibody.
    Millet P; Collins WE; Herman L; Cochrane AH
    Exp Parasitol; 1989 Jul; 69(1):91-3. PubMed ID: 2659376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of antibodies to vivax-malaria by ELISA using in vitro cultured erythrocytic Plasmodium cynomolgi as antigen].
    Wang XZ; Li ST; Xi YH; Ye JS; Zhou ZX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(1):29-31. PubMed ID: 3289786
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship.
    Lal AA; Patterson PS; Sacci JB; Vaughan JA; Paul C; Collins WE; Wirtz RA; Azad AF
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5228-33. PubMed ID: 11309510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Pvs28 in sporozoite development in Anopheles sinensis and its longevity in BALB/c mice.
    Kim TS; Kim HH; Moon SU; Lee SS; Shin EH; Oh CM; Kang YJ; Kim DK; Sohn Y; Kim H; Lee HW
    Exp Parasitol; 2011 Feb; 127(2):346-50. PubMed ID: 20801117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720.
    Saul A; Hensmann M; Sattabongkot J; Collins WE; Barnwell JW; Langermans JA; Wu Y; Long CA; Dubovsky F; Thomas AW
    Parasite Immunol; 2007 Oct; 29(10):525-33. PubMed ID: 17883455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax polymorphs and Plasmodium falciparum circumsporozoite proteins in Anopheles (Diptera: Culicidae) from Belize, Central America.
    Achee NL; Korves CT; Bangs MJ; Rejmankova E; Lege M; Curtin D; Lenares H; Alonzo Y; Andre RG; Roberts DR
    J Vector Ecol; 2000 Dec; 25(2):203-11. PubMed ID: 11217218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of a strain of Plasmodium vivax from Mauritania to New World monkeys and anopheline mosquitoes.
    Collins WE; Nguyen-Dinh P; Sullivan JS; Morris CL; Galland GG; Richardson BB; Nesby S
    J Parasitol; 1998 Jun; 84(3):619-21. PubMed ID: 9645868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes.
    Arévalo-Herrera M; Vallejo AF; Rubiano K; Solarte Y; Marin C; Castellanos A; Céspedes N; Herrera S
    PLoS One; 2015; 10(3):e0119335. PubMed ID: 25775466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets of protective antibodies to malaria during pregnancy.
    Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
    J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of monoclonal antibodies against a 19-kD recombinant Plasmodium vivax MSP1 for detection of P. vivax malaria in Turkey.
    Ak M; Babaoğlu A; Dağci H; Türk M; Bayram S; Ertabaklar H; Ozcel MA; Uner A; Charoenvit Y; Kumar S; Hoffman SL
    Hybrid Hybridomics; 2004 Apr; 23(2):133-6. PubMed ID: 15165487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
    Ramjanee S; Robertson JS; Franke-Fayard B; Sinha R; Waters AP; Janse CJ; Wu Y; Blagborough AM; Saul A; Sinden RE
    Vaccine; 2007 Jan; 25(5):886-94. PubMed ID: 17049690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transmission-blocking immunity on Plasmodium vivax infections in Anopheles albimanus populations.
    Ramsey JM; Salinas E; Rodriguez MH; Beaudoin RL
    J Parasitol; 1994 Feb; 80(1):88-92. PubMed ID: 8308663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.